Head and Neck TumorsHead and Neck TumorsОпухоли головы и шеи2222-14682411-4634Publishing House ABV Press18010.17650/2222-1468-2015-5-4-11-15DIAGNOSIS AND TREATMENT OF HEAD AND NECK TUMORSДИАГНОСТИКА И ЛЕЧЕНИЕ ОПУХОЛЕЙ ГОЛОВЫ И ШЕИDiagnostic features of lung metastases differentiated thyroid cancerОсобенности диагностики метастазов в легкие дифференцированного рака щитовидной железыGeliashviliT. M.ГелиашвилиТ. М.
Russian Federation

42 Blyukhera St., Chelyabinsk, 454087

454087, Челябинск, ул. Блюхера, 42

geliashvili_tata@mail.ruVazheninA. V.ВаженинА. В.
Russian Federation

42 Blyukhera St., Chelyabinsk, 454087

454087, Челябинск, ул. Блюхера, 42

Vasil’evaE. B.ВасильеваЕ. Б.
Russian Federation

42 Blyukhera St., Chelyabinsk, 454087

454087, Челябинск, ул. Блюхера, 42

Afanas’evaN. G.АфанасьеваН. Г.
Russian Federation

42 Blyukhera St., Chelyabinsk, 454087

454087, Челябинск, ул. Блюхера, 42

Chelyabinsk Regional Clinical Oncology CenterГБУЗ «Челябинский областной клинический онкологический диспансер»301220155411151601201616012016Copyright ©; 2015, Geliashvili T.M., Vazhenin A.V., Vasil’eva E.B., Afanas’eva N.G.Copyright ©; 2015, Гелиашвили Т.М., Важенин А.В., Васильева Е.Б., Афанасьева Н.Г.2015Geliashvili T.M., Vazhenin A.V., Vasil’eva E.B., Afanas’eva N.G.Гелиашвили Т.М., Важенин А.В., Васильева Е.Б., Афанасьева Н.Г.https://creativecommons.org/licenses/by/4.0https://ogsh.abvpress.ru/jour/article/view/180

differentiated thyroid cancerlung metastaseschest X-ray18fluorodeoxyglucose positron emission tomography / computed tomographymultislice spiral computed tomography of the chest131I whole-body scintigraphyдифференцированный рак щитовидной железыметастазы в легкиерентгенография органов грудной клеткипозитронная эмиссионная томография / компьютерная томография с 18-фтордезоксиглюкозоймультиспиральная компьютерная томография грудной клеткисцинтиграфия всего тела с I1311. Каприн А.Д., Старинский В.В., Петрова Г.В. Злокачественные новообразования в России в 2012 году (заболеваемость и смертность). М., 2014. [Kaprin А.D., Starinsky V.V., Petrovа G.V. Malignant tumors in Russia in 2012 (morbidity and fatality). Мoscow, 2014. (In Russ.)].Каприн А.Д., Старинский В.В., Петрова Г.В. Злокачественные новообразования в России в 2012 году (заболеваемость и смертность). М., 2014. [Kaprin А.D., Starinsky V.V., Petrovа G.V. Malignant tumors in Russia in 2012 (morbidity and fatality). Мoscow, 2014. (In Russ.)].2. Sherman S.I. Thyroid carcinoma. Lancet 2003;361(9356):501–11.Sherman S.I. Thyroid carcinoma. Lancet 2003;361(9356):501–11.3. Sipos J.A., Mazzaferri E.L. Thyroid cancer epidemiology and prognostic variables. Clin Oncol (R Coll Radiol) 2010;22(6):395–404.Sipos J.A., Mazzaferri E.L. Thyroid cancer epidemiology and prognostic variables. Clin Oncol (R Coll Radiol) 2010;22(6):395–404.4. Davies L., Welch H.G. Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 2006;295(10): 2164–7.Davies L., Welch H.G. Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 2006;295(10): 2164–7.5. Eustatia-Rutten C.F., Corssmit E.P., Biermasz N.R. et al. Survival and death causes in differentiated thyroid carcinoma. J Clin Endocrinol Metab 2006;91(1):313–9.Eustatia-Rutten C.F., Corssmit E.P., Biermasz N.R. et al. Survival and death causes in differentiated thyroid carcinoma. J Clin Endocrinol Metab 2006;91(1):313–9.6. O’Neill C.J., Oucharek J., Learoyd D., Sidhu S.B. Standard and emerging therapies for metastatic differentiated thyroid cancer. Oncologist 2010;15(2):146–56.O’Neill C.J., Oucharek J., Learoyd D., Sidhu S.B. Standard and emerging therapies for metastatic differentiated thyroid cancer. Oncologist 2010;15(2):146–56.7. Durante C., Haddy N., Baudin E. et al. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: Benefits and limits of radioiodine therapy. J Clin Endocrinol Metab 2006;91(8):2892–9.Durante C., Haddy N., Baudin E. et al. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: Benefits and limits of radioiodine therapy. J Clin Endocrinol Metab 2006;91(8):2892–9.8. Dinneen S.F., Valimaki M.J., Bergstralh E.J. et al. Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades. J Clin Endocrinol Metab 1995;80(7):2041–5.Dinneen S.F., Valimaki M.J., Bergstralh E.J. et al. Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades. J Clin Endocrinol Metab 1995;80(7):2041–5.9. Валдина Е.А. Заболевания щитовидной железы. СПб.: Питер, 2006. [Valdinа Е.А. Thyroid gland diseases. Saint-Petersburg: Piter, 2006. (In Russ.)].Валдина Е.А. Заболевания щитовидной железы. СПб.: Питер, 2006. [Valdinа Е.А. Thyroid gland diseases. Saint-Petersburg: Piter, 2006. (In Russ.)].10. Showalter T.N., Siegel B.A., Moley J.F. et al. Prognostic factors in patients with welldifferentiated thyroid cancer presenting with pulmonary metastasis. Cancer Biother Radiopharm 2008;23(5):655–9.Showalter T.N., Siegel B.A., Moley J.F. et al. Prognostic factors in patients with welldifferentiated thyroid cancer presenting with pulmonary metastasis. Cancer Biother Radiopharm 2008;23(5):655–9.11. Sampson E., Brierley J.D., Le L.W. et al. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis. Cancer 2007;110(7):1451–6.Sampson E., Brierley J.D., Le L.W. et al. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis. Cancer 2007;110(7):1451–6.12. Schlumberger M.J. Diagnostic follow-up of well-differentiated thyroid carcinoma: Historical perspective and current status. J Endocrinol Invest 1999;22(11 Suppl):3–7.Schlumberger M.J. Diagnostic follow-up of well-differentiated thyroid carcinoma: Historical perspective and current status. J Endocrinol Invest 1999;22(11 Suppl):3–7.13. Casara D., Rubello D., Saladini G. et al. Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate analysis of prognostic variables. J Nucl Med 1993;34(10):1626–31.Casara D., Rubello D., Saladini G. et al. Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate analysis of prognostic variables. J Nucl Med 1993;34(10):1626–31.14. Schlumberger M.J., Arcangioli O., Piekarski J.D. et al. Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest X-rays. J Nucl Med 1988;29(11):1790–4.Schlumberger M.J., Arcangioli O., Piekarski J.D. et al. Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest X-rays. J Nucl Med 1988;29(11):1790–4.15. Wang H., Fu H.L., Li J.N. et al. Comparison of whole-body 18F-FDG SPECT and posttherapeutic 131I scintigraphy in the detection of metastatic thyroid cancer. Clin Imaging 2008;32(1):32–7.Wang H., Fu H.L., Li J.N. et al. Comparison of whole-body 18F-FDG SPECT and posttherapeutic 131I scintigraphy in the detection of metastatic thyroid cancer. Clin Imaging 2008;32(1):32–7.16. Hooft L., Hoekstra O.S., Devillé W. et al. Diagnostic accuracy of 18Ffluorodeoxyglucose positron emission tomography in the follow-up of papillary or follicular thyroid cancer. J Clin Endocrinol Metab 2001;86(8):3779–86.Hooft L., Hoekstra O.S., Devillé W. et al. Diagnostic accuracy of 18Ffluorodeoxyglucose positron emission tomography in the follow-up of papillary or follicular thyroid cancer. J Clin Endocrinol Metab 2001;86(8):3779–86.17. Khan N., Oriuchi N., Higuchi T. et al. PET in the follow-up of differentiated thyroid cancer. Br J Radiol 2003;76(910): 690–5.Khan N., Oriuchi N., Higuchi T. et al. PET in the follow-up of differentiated thyroid cancer. Br J Radiol 2003;76(910): 690–5.18. Sisson J.C., Ackermann R.J., Meyer M.A., Wahl R.L. Uptake of 18-fluoro-2-deoxy-Dglucose by thyroid cancer: implications for diagnosis and therapy. J Clin Endocrinol Metab 1993;77(4):1090–4.Sisson J.C., Ackermann R.J., Meyer M.A., Wahl R.L. Uptake of 18-fluoro-2-deoxy-Dglucose by thyroid cancer: implications for diagnosis and therapy. J Clin Endocrinol Metab 1993;77(4):1090–4.